Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

NVST

STRONG BUYAPPROVE

Envista Holdings Corporation · Healthcare · United States · $4.3B · Avg Vol: $67M/d

89
StockRank
Get insider-trade alerts
Q
58
V
50
M
79
P/E (TTM)
64.8x
ROE
2.2%
D/E
0.5x
Dividend %
AI CONVICTION THESIS

Envista Holdings clears the calibrated bar. All three legs are above the floor (Q57 V51 M78) and an active buyback provides the required corroboration. Nothing adverse is on file: no negative earnings revision and no insider selling. Strong momentum at M78 suggests the market is beginning to confirm the dental recovery.

COMPANY DESCRIPTION

Envista Holdings Corporation manufactures and distributes dental products, including consumables, equipment, and digital imaging solutions, serving dental professionals worldwide. It leverages a broad portfolio of well-known dental brands and a global sales and distribution network to maintain its competitive standing. Spun off from Danaher Corporation, Envista is a significant player in the dental industry with a focus on innovation and digital dentistry.

FINANCIAL SUMMARY (USD)

Year20212022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue2.6B2.6B2.5B2.7B1.9%2.8B2.9B3.0B4.3%
EPS2.111.49-0.60-6.500.28-39.6%0.410.340.3715.0%
Shares163.2M171.5M172.2M163.8M+0.4%162.7M
Debt1.5B1.7B1.5B1.6B1.5%1.6B
Equity4.2B4.2B2.9B3.1B-9.6%
Op CF182.7M275.7M336.5M275.7M14.7%272.1M
Inv CF-657.3M-62.4M-54.6M-51.1M
Fin CF12.5M118.9M-103.7M-170.9M
Loading 1Y...
PRICE (1Y)+7.5%
24.5025.2826.0626.8527.63Jun 11Jul 6Jul 24
SMA 50SMA 200
Close
$26.33
RSI (14)
38.0
52W High
$30.42
From 52W High
0.9%

SCORE BREAKDOWN

Quality
58
ROIC
4.4%56.4
ROE
2.2%50.1
GP/Assets
27.3%61.9
Op. Margin
9.9%66.4
FCF/Assets
3.8%63.8
Piotroski
783.4
Int. Cover
5.8x53.4
D/E Ratio
0.52x29.7
Current Ratio
2.44x45.9
Value
50
P/E (TTM)
64.8x15.5
EV/EBITDA
12.6x56.9
P/FCF
19.8x59.8
P/B
1.4x73.9
P/S
1.5x74.4
Div Yield
N/A
Momentum
79
52W High %
87%79.9
RS 6M
0%74.0
SMA 50/200
1.04x72.9
EPS Rev 4W
+0.1%77.3
EPS Rev 12W
+0.9%66.7
EPS Improve
+284%92.2
Q Growth
115%86.7

FUNDAMENTALS

Market Cap
$4.3B
P/E (Forward)
16.9x
Gross Margin
55.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NVST are excluded.

TickerCompanyMkt CapStockRankSignal
NVSTEnvista Holdings Corporation(you)$4.3B89STRONG BUY
ICUIICU Medical, Inc.$3.9B82STRONG BUY
MMSIMerit Medical Systems, Inc.$4.4B78BUY
ALGNAlign Technology, Inc.$12.0B93STRONG BUY
TFXTeleflex Incorporated$5.8B70BUY
XRAYDENTSPLY SIRONA Inc.$2.6B73BUY
LMATLeMaitre Vascular, Inc.$2.2B75BUY
ATRAptarGroup, Inc.$8.4B74BUY
SOLVSolventum Corporation$13.5B78BUY
AVTRAvantor, Inc.$7.8B62HOLD

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%

Envista Holdings Corporation (NVST) — Stock Score Summary

Envista Holdings Corporation (NVST) has a MoatMap StockRank of 89/100 based on Quality (58/100), Value (50/100), and Momentum (79/100) factor scores. The current signal is STRONG BUY. Envista Holdings clears the calibrated bar. All three legs are above the floor (Q57 V51 M78) and an active buyback provides the required corroboration. Nothing adverse is on file: no negative earnings revision and no insider selling. Strong momentum at M78 suggests the market is beginning to confirm the dental recovery.

Envista Holdings Corporation manufactures and distributes dental products, including consumables, equipment, and digital imaging solutions, serving dental professionals worldwide. It leverages a broad portfolio of well-known dental brands and a global sales and distribution network to maintain its competitive standing. Spun off from Danaher Corporation, Envista is a significant player in the dental industry with a focus on innovation and digital dentistry.

Key Financial Metrics

Price$26.33
Market Cap$4.3B
P/E (TTM)64.83
P/E (Forward)16.90
Price/Book1.41
Return on Equity2.2%
Return on Invested Capital4.4%
Debt/Equity0.52x
Gross Margin55.3%
Operating Margin9.9%
Revenue Growth14.4%
Free Cash Flow$216M

Envista Holdings Corporation operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Envista Holdings Corporation’s (NVST) StockRank?
MoatMap’s StockRank for Envista Holdings Corporation (NVST) is 89/100, with a Strong Buy signal. It is a composite of Quality (58), Value (50), and Momentum (79) factor ranks across MoatMap’s 20,000+ stock universe.
Does Envista Holdings Corporation have an economic moat?
Envista Holdings Corporation (NVST) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Envista Holdings Corporation a buy, hold, or sell?
MoatMap’s current signal for Envista Holdings Corporation (NVST) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Envista Holdings Corporation in?
Envista Holdings Corporation (NVST) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).